通过退伍军人管理局SCAN-ECHO项目进行的虚拟会诊可改善肝病退伍军人的生存率
该研究在退伍军人健康管理局(VHA)区域性肝病队列(n=62,237)中,评估2011年6月1日至2015年3月31日期间SCAN-ECHO虚拟会诊对全因死亡率的影响。经倾向性评分匹配后,SCAN-ECHO会诊与全因死亡率的风险比为0.54(95%CI 0.36-0.81,P=0.003)。结论认为SCAN-ECHO可能是一种改善特定肝病患者专科就诊可及性的有效方法。
要点
- SCAN-ECHO虚拟会诊与全因死亡率风险比为0.54(95%CI 0.36-0.81,P=0.003)。
- 完成虚拟SCAN-ECHO会诊的患者更年轻、更多为农村居民、肝病更严重且有肝硬化证据。
- SCAN-ECHO可能是一种改善农村和医疗服务不足人群专科就诊可及性的有效方法。
核心结论
- SCAN-ECHO虚拟会诊与肝病退伍军人全因死亡率降低相关,风险比为0.54(95%CI 0.36-0.81,P=0.003)。
- 作者认为SCAN-ECHO可能是一种改善特定肝病患者专科就诊可及性的有效方法,尤其适用于农村和医疗服务不足人群。
研究设计与样本
- 研究为在VHA区域性肝病队列(n=62,237)中评估SCAN-ECHO会诊效果的分析,实施时间为2011年6月1日至2015年3月31日。
- 研究比较了接受SCAN-ECHO会诊的患者与未就诊肝病门诊患者的全因死亡率,并采用倾向性评分匹配调整人口学、地理位置、肝病诊断、严重程度和合并症等因素。
主要发现
- 研究期间队列中共有513例患者接受了肝脏SCAN-ECHO会诊。
- 完成虚拟SCAN-ECHO会诊的患者更年轻、更多为农村居民、肝病更严重且有肝硬化证据。
- 经倾向性评分调整的Cox比例风险模型显示,SCAN-ECHO会诊与未就诊相比的全因死亡率风险比为0.54(95%CI 0.36-0.81,P=0.003)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Access to specialty care has been associated with improved survival in patients with liver disease but universal access is not always feasible. Methods of care delivery using virtual modalities including the SCAN-ECHO (Specialty Access Network-Extension of Community Healthcare Outcome) program were implemented by the Veterans Health Administration (VHA) to address this need but limited data are available on patient outcomes. We sought to evaluate the efficacy of a SCAN-ECHO visit within the context of a regional cohort of patients with liver disease in the VHA (n = 62,237) following implementation in the Ann Arbor SCAN-ECHO Liver Clinic from June 1, 2011, to March 31, 2015. The effect of a SCAN-ECHO visit on all-cause mortality was compared with patients with no liver clinic visit. To adjust for the differences among patients who had a SCAN-ECHO visit versus those with no visit, propensity score matching was performed on condition factors that affect the likelihood of a SCAN-ECHO visit: demographics, geographic location, liver disease diagnosis, severity, and comorbidities. During the study period, 513 patients who had a liver SCAN-ECHO visit were found within the cohort. Patients who had completed a virtual SCAN-ECHO visit were more likely younger, rural, with more significant liver disease, and evidence for cirrhosis. Propensity-adjusted mortality rates using the Cox Proportional Hazard Model showed that a SCAN-ECHO visit was associated with a hazard ratio of 0.54 (95% confidence interval 0.36-0.81, P = 0.003) compared with no visit. Conclusion: Improved survival in patients using SCAN-ECHO suggests that this approach may be an effective method to improve access for selected patients with liver disease, particularly in rural and underserved populations where access to specialty care is limited.
引用
- Su GL, Glass L, Tapper EB, et al. Virtual Consultations Through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans With Liver Disease. Hepatology. 2018. PMID: 29729194. doi:10.1002/hep.30074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。